NEW YORK (GenomeWeb News) — Bar Harbor Biotechnology has closed a “multi-million dollar” round of Series A financing and plans to use the cash to market its first product, the company said Tuesday.
 
Bar Harbor Biotechnology, based in Trenton, Maine, is developing a suite of gene-expression products that includes bioanalysis software, qPCR arrays, and bioinformatics applications for gene-expression experiments.
  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.